# Pituitary Macroadenoma and Visual Field Defects

> Pituitary macroadenoma and visual field defects for NEET-PG Medicine, covering chiasm compression, bitemporal hemianopia and subtype-based adenoma treatment.

- Canonical URL: https://prepelephant.com/topics/neet-pg/medicine/pituitary-macroadenoma-and-visual-field-defects
- Exam / course: NEET-PG · Subject: Medicine
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-14
- Last updated: 2026-10-14
- Reference basis: Williams Textbook of Endocrinology; Kanski's Clinical Ophthalmology
- How to cite: "Pituitary Macroadenoma and Visual Field Defects", PrepElephant, https://prepelephant.com/topics/neet-pg/medicine/pituitary-macroadenoma-and-visual-field-defects

## Direct answer

A pituitary macroadenoma is a pituitary tumour larger than 1 cm, and its suprasellar growth compresses the optic chiasm to produce visual field loss. The classic first defect is bitemporal superior quadrantanopia, which can progress to bitemporal hemianopia. Management depends on the hormone the tumour secretes, with surgery, dopamine agonists, somatostatin analogues or observation chosen by subtype.

## What you must remember

- **Definition:** a pituitary adenoma larger than 1 cm; smaller tumours are microadenomas.
- **Chiasm compression:** suprasellar extension presses on the optic chiasm from below.
- **Classic field defect:** bitemporal superior quadrantanopia, progressing to bitemporal hemianopia.
- **Other mass effects:** headache, cavernous sinus palsies of the third, fourth or sixth nerves, and hypopituitarism.
- **Prolactinoma:** the commonest functioning adenoma; dopamine agonists such as cabergoline are first line.
- **GH-secreting adenoma:** causes acromegaly; surgery is first line, with somatostatin analogues or pegvisomant as needed.
- **ACTH-secreting adenoma:** causes Cushing disease; transsphenoidal surgery is first line.
- **Non-functioning adenoma:** the commonest subtype of macroadenoma; surgery is indicated for mass effect, and small tumours may be observed.

## A stepwise approach to a sellar mass with visual loss

A large sellar mass with a narrowing field of vision needs timely decisions on decompression and hormone treatment. The sequence below sets out a practical order of tests and management.

1. **Test the fields formally:** perimetry maps the pattern and tracks progression, and visual acuity and colour vision are checked alongside it.
2. **Measure hormones:** prolactin, IGF-1, cortisol and ACTH, TSH with free T4, and LH, FSH and sex steroids, along with sodium.
3. **Image the sella:** contrast MRI defines the extent, cavernous sinus involvement and the relation to the optic chiasm.
4. **Choose treatment by subtype:** dopamine agonists are used first for prolactinomas, while transsphenoidal surgery is the usual choice for ACTH-secreting and non-functioning tumours.
5. **Decompress for progressive loss:** urgent surgery is indicated when fields or acuity worsen, because recovery is better when compression is relieved early.
6. **Follow up:** repeat fields, hormone levels and MRI, and replace any deficient axes.

## Where students lose marks

Examiners return to these traps when they test this topic.

- **Trap:** treating every macroadenoma surgically. — **Correct:** prolactinomas usually shrink with dopamine agonists, so surgery is reserved for failed medical therapy.
- **Trap:** expecting bitemporal hemianopia as the earliest defect. — **Correct:** superior quadrantanopia from pressure on the inferior chiasm is typically the first sign.
- **Trap:** assuming visual loss always recovers after surgery. — **Correct:** recovery depends on how long the chiasm has been compressed, so early decompression gives the best chance.

## Frequently asked questions

### Why does a pituitary macroadenoma cause bitemporal hemianopia?

A pituitary macroadenoma causes bitemporal hemianopia by compressing the optic chiasm, where the nasal fibres from both eyes cross. Pressure from below affects the inferior crossing fibres first, giving superior field loss. Continued growth extends the loss into full bitemporal hemianopia.

### Which pituitary adenoma is treated first with dopamine agonists?

Prolactinomas are the adenomas treated first with dopamine agonists such as cabergoline or bromocriptine. Many shrink substantially and normalise prolactin on medication. Surgery is reserved for patients who do not respond to dopamine agonists or cannot tolerate them.

### What is the first-line treatment for a non-functioning macroadenoma with visual loss?

Transsphenoidal surgery is the first-line treatment for a non-functioning pituitary macroadenoma that is causing visual loss. Decompression aims to relieve chiasm pressure before the field loss becomes permanent. Medical therapy is not effective for non-functioning tumours, which are managed surgically when mass effect is present.

### Which investigation defines the visual field defect in a pituitary adenoma?

Formal perimetry, such as Humphrey visual field testing or Goldmann kinetic perimetry, defines the pattern and extent of the field defect. Visual acuity and colour vision are checked alongside it. Serial testing tracks progression, and MRI shows the compressing mass.